FASTHEADLINENEWS

$RTX Headlines

30 trading headlines for $RTX

Apr 2 05:01 PM

RTX (NYSE:RTX) Price Target Lowered to $226.00 at Citigroup

analystAlphaVantage

Apr 2 04:36 PM

Citigroup Maintains Buy on RTX, Lowers Price Target to $226

analystAlpaca

Apr 2 11:08 AM

As Trump Threatens NATO Exit, Schumer Reminds Marco Rubio Of His Own Law Blocking Any Quick Withdrawal— 'Couldn't Act On A Whim'

generalAlpaca

Apr 1 08:05 PM

Trading Trump's 9 P.M. Address: Nuclear, Epic Fury And The $2M Word Market

macroAlpaca

Apr 1 07:30 PM

Trump Toys With NATO Exit: Defense Stocks In The Crosshairs

macroAlpaca

Apr 1 07:18 PM

$1.4T In NATO Defense Spending Is Just The Beginning: 5 Stocks Positioned For The Buildup

generalAlpaca

Apr 1 05:02 PM

XORTX Therapeutics Announces 1-For-5 Share Consolidation, Effective April 6, 2026

generalAlpaca

Apr 1 05:01 PM

Vertex Pharmaceuticals (NASDAQ: VRTX) reports 978-share Rule 144 resale and insider sales

insiderAlphaVantage

Apr 1 04:59 PM

RTX's BBN Technologies launches open-source tool to validate covert cyber networks

corporateAlphaVantage

Apr 1 02:42 PM

Wells Fargo Initiates Coverage On RTX with Equal-Weight Rating, Announces Price Target of $200

analystAlpaca

Apr 1 12:35 PM

As Rock 'n' Roll Era Bombers Head To Iran, Boeing's Stock Is Taking Off Too

macroAlpaca

Apr 1 11:35 AM

The FDA Approves Expanded Use Of Vertex Pharmaceuticals' ALYFTREK (vanzacaftor/tezacaftor/ivacaftor) For Cystic Fibrosis In Patients 6 And Older

fdaAlpaca

Mar 31 08:23 PM

Vertex Pharmaceuticals Submits Povetacicept For The Treatment Of Immunoglobulin A Nephropathy For Accelerated Approval From The FDA; Expects FDA Review To Be Accelerated From Usual 10-Month Review Period To 6-Month Review

fdaAlpaca

Mar 31 08:01 PM

Here's How Much $1000 Invested In RTX 5 Years Ago Would Be Worth Today

generalAlpaca

Mar 31 06:08 PM

Why Is RTX Corporation Stock Gaining Tuesday?

generalAlpaca

Mar 31 04:19 PM

RTX F135 Win Deepens F 35 Ties And Long Term Defense Exposure

generalAlphaVantage

Mar 31 01:07 PM

Pratt & Whitney Awarded $3.8B Contract Modification For F135 Engines; Total Lots 18-19 Production Value Reaches $6.6B To Support F-35 Lightning II Program

corporateAlpaca

Mar 30 09:30 PM

If You Invested $1000 In Vertex Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today

generalAlpaca

Mar 30 12:05 PM

BioRestorative Announces Blinded Data From Phase 2 Clinical Trial Evaluating Hypoxic-Cultured Mesenchymal Stem Cells For Treatment Of Chronic Lumbar Disc Disease; Data Shows 50% Or More Of Patients Reporting >50% Improvement In Key Pain And Function Scales

fdaAlpaca

Mar 27 05:13 PM

Watching Vertex Pharmaceuticals; Shares Trading Lower, FDA Label Update For ALYFTREK Adds Neuropsychiatric Risk Warning And Intracranial Hypertension, Alongside Strengthened Liver Safety Monitoring

fdaAlpaca

Mar 27 12:47 PM

'U.S. uses hundreds of Tomahawk missiles on Iran, alarming some at Pentagon' - Washington Post

macroAlpaca

Mar 26 09:49 PM

BioRestorative Therapies Q4 EPS $(0.32) Misses $(0.30) Estimate, Sales $19.600K Miss $520.000K Estimate

earningsAlpaca

Mar 26 08:42 PM

XORTX Therapeutics Delays 1-for-5 Share Consolidation To April 6, Pending Approvals

fdaAlpaca

Mar 25 05:12 PM

General Electric Deepens Nuclear And Aerospace Commitments With Long Cycle Bets

generalAlphaVantage

Mar 25 02:47 PM

Why Is Palantir Stock Rising On Wednesday?

generalAlpaca

Mar 25 12:26 PM

Jamie Dimon 'Deeply Frustrated' By US Defense Rigidities; 'Little Optimistic' On Middle East Peace

generalAlpaca

Mar 25 05:30 AM

Palantir And Palmer Luckey's Anduril Team Up On Trump's $185 Billion Golden Dome Missile Shield: Report

macroAlpaca

Mar 24 04:59 PM

RTX Corporation stock faces headwinds from missile settlement and supply chain woes amid surging defense demand

macroAlphaVantage

Mar 24 07:03 AM

Sean Duffy Says Revamped Air Traffic Control 'Top Priority' Following LaGuardia Crash: 'It's Not About Politics…'

generalAlpaca

Mar 23 05:05 PM

Time to Reduce RTX Exposure as Trump Looks to Wind Down Iran Conflict

macroAlphaVantage